TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36127557

Group type: EXPERIMENTAL
Intervention: Robotic Gastrectomy (RG)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Open Gastrectomy (OG)
Number of subjects: 65
Study: 32250463

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg twice daily (Day 8) and once daily (Days 9–16) with a single oral 2.5 mg dose of esaxerenone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg once daily (Days 8–16) with a single oral 5 mg dose of esaxerenone
Number of subjects: 32
Study: 33378776

Group type: EXPERIMENTAL
Intervention: Lateral colostomy (LC)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Conventional colostomy (CC)
Number of subjects: 203
Study: 33337397

Group type: EXPERIMENTAL
Intervention: Computerized Balance Training + Conventional Physiotherapy (40 minutes once a day, 5 times a week for 4 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional Physiotherapy (40 minutes twice a day, 5 times a week for 4 weeks)
Number of subjects: 32
Study: 35368096

Group type: EXPERIMENTAL
Intervention: PAC quality improvement interventions emphasizing family planning counseling and voluntary access to LARC in mainland Tanzania.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PAC quality improvement interventions emphasizing family planning counseling and voluntary access to LARC in Zanzibar.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PAC quality improvement interventions in Zanzibar.
Number of subjects: 0
Study: 33616561

Group type: EXPERIMENTAL
Intervention: Two-implant mandibular overdentures (IODs)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional mandibular dentures relined (RCD)
Number of subjects: 29
Study: 35764668

Group type: EXPERIMENTAL
Intervention: Mindfulness- and self-compassion-based group intervention with animal-assistance (n=14)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Mindfulness- and self-compassion-based group intervention without animal-assistance (n=17)
Number of subjects: 31
Study: 34099068

Group type: EXPERIMENTAL
Intervention: Mitochondrial genome copy number (MT-CN)
Number of subjects: 19184

Group type: EXPERIMENTAL
Intervention: MT-CN polygenic risk score (PRS)
Number of subjects: 19184

Group type: EXPERIMENTAL
Intervention: MT-CN
Number of subjects: 19184
Study: 32164604

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Exercise plus weight management intervention
Number of subjects: 415

Group type: COMPARATOR
Intervention: Information-only control group
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 415
Study: 35500658

Group type: EXPERIMENTAL
Intervention: WingCap-assisted colonoscopy
Number of subjects: 537

Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 537
Study: 34259798

Group type: COMPARATOR
Intervention: Usual care (information about contraceptive methods and community health care facilities)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Onsite contraceptive services (adapted from WHO) with 6 months of follow-up visits
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Onsite contraceptive services plus financial incentives for attending follow-up visits
Number of subjects: 138
Study: 35749114

Group type: EXPERIMENTAL
Intervention: Unsolicited telephone infectious disease consultations (IDCs) provided by ID specialists from Jena University Hospital
Number of subjects: 386

Group type: COMPARATOR
Intervention: Control group treated according to local standards
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Unsolicited telephone IDCs
Number of subjects: 386

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 386
Study: 34770233

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) using RSQ1 device (10 sessions)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Isometric training (control group)
Number of subjects: 19
Study: 34515552

Group type: EXPERIMENTAL
Intervention: Individualized oral health education (OHE) via a behavioral and educational counseling approach
Number of subjects: 580

Group type: COMPARATOR
Intervention: OHE pamphlets only (control group)
Number of subjects: 580
Study: 32068603

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of conbercept (IVC) 7 days before vitrectomy (group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of conbercept (IVC) 14 days before vitrectomy (group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No intravitreal injection of conbercept (non-IVC, group C)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-diabetic control group (group D)
Number of subjects: 80
Study: 35033000

Group type: EXPERIMENTAL
Intervention: Mindful Kangaroo Care (MKC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care (no mindfulness teaching)
Number of subjects: 30
Study: 32803798

Group type: COMPARATOR
Intervention: Xenograft BO (Bio-Oss)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Xenograft EB (EndoBon)
Number of subjects: 24
Study: 35878047

Group type: EXPERIMENTAL
Intervention: Computerized Cognitive Rehabilitation Therapy (CCRT) - 24 biweekly 90-min sessions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 30
Study: 34479556

Group type: EXPERIMENTAL
Intervention: Implementation strategy consisting of a combined peer navigator and a health information technology (HIT) package.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focus group discussions (FGDs) with community stakeholders.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Likert-scale survey during FGDs.
Number of subjects: 0
Study: 32471973

Group type: EXPERIMENTAL
Intervention: Aprepitant (125 mg on the 1st day and 80 mg during the following days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35381432

Group type: EXPERIMENTAL
Intervention: Alcohol condition (0.10% BrAC)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 390
Study: 32086551

Group type: EXPERIMENTAL
Intervention: Testosterone administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32279561

Group type: EXPERIMENTAL
Intervention: Bare-metal stents (BMS)
Number of subjects: 10987

Group type: EXPERIMENTAL
Intervention: First-generation drug-eluting stents (DES1)
Number of subjects: 10987

Group type: EXPERIMENTAL
Intervention: Second-generation drug-eluting stents (DES2)
Number of subjects: 10987
Study: 35334422

Group type: EXPERIMENTAL
Intervention: IMB model‐based, 12‐week osteoporosis prevention program
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 33832167

Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation (varied stimulation quantity across 9 groups A1-A9)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control conditions (time and frequency)
Number of subjects: 100
Study: 36066520

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including educational outreach, computerized clinical decision support on contrast volume and hemodynamic‐guided intravenous fluid targets, and audit and feedback.
Number of subjects: 7106

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 7106

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 7106
Study: 34600060

Group type: EXPERIMENTAL
Intervention: API tablets at low and high compression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: API tablets
Number of subjects: 0
Study: 36301724

Group type: EXPERIMENTAL
Intervention: Volatile anesthesia (sevoflurane or desflurane)
Number of subjects: 684

Group type: COMPARATOR
Intervention: Propofol‐based total intravenous anesthesia (TIVA)
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Volatile anesthesia
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 684
Study: 34533070

Group type: EXPERIMENTAL
Intervention: 8-hour sexual health care training
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 75
Study: 35266774

Group type: EXPERIMENTAL
Intervention: Positive parenting intervention
Number of subjects: 65

Group type: COMPARATOR
Intervention: Attention control intervention
Number of subjects: 65
Study: 32413174

Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty (HA)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Internal fixation (IF)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Conservative treatment (CST)
Number of subjects: 154
Study: 33908294

Group type: EXPERIMENTAL
Intervention: Supervised Pilates-based core stability training (PBCST) 2 days per week for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Home Pilates-based core stability training (PBCST)
Number of subjects: 50
Study: 33781142

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100/25 µg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 32307009

Group type: EXPERIMENTAL
Intervention: Group PM+ (five sessions of approximately 2.5 hours each, delivered by trained community psychosocial workers)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC) consisting of a family meeting with information on adversity, mental health, and local health services
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Group PM+
Number of subjects: 72

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 72
Study: 35491239

Group type: EXPERIMENTAL
Intervention: 20% albumin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 12
Study: 32208176

Group type: EXPERIMENTAL
Intervention: 12-week moderate intensity aerobic exercise (60 min/day, 3 days/week at 70% of maximal heart rate reserve)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 5-month detraining after 12-week exercise
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (maintained normal lifestyle)
Number of subjects: 31
Study: 33662995

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no homeopathic treatment)
Number of subjects: 0
Study: 32645134

Group type: EXPERIMENTAL
Intervention: Statistical guidelines for experimental design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Power analysis for sample size selection
Number of subjects: 0
Study: 34558147

Group type: EXPERIMENTAL
Intervention: Nurse-led online educational programme
Number of subjects: 800

Group type: COMPARATOR
Intervention: Routine health education and doctor-led follow-up
Number of subjects: 800
Study: 34696764

Group type: EXPERIMENTAL
Intervention: Virtual reality training (VRT) + lifestyle education for 8 weeks (24 sessions, 40 min each)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (lifestyle education only)
Number of subjects: 26
Study: 32828737

Group type: EXPERIMENTAL
Intervention: Meal, Ready‐to‐Eat (MRE) diet for 21 days followed by usual diet for 10 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual diet for 31 days (CON)
Number of subjects: 60
Study: 35568571

Group type: EXPERIMENTAL
Intervention: 3-session motivational enhancement therapy (MET)
Number of subjects: 742

Group type: COMPARATOR
Intervention: 8-session social behaviour and network therapy (SBNT)
Number of subjects: 742
Study: 33832806

Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block with 20 mL per side of 0.25% levobupivacaine (group E)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham block with 20 mL of normal saline (group C)
Number of subjects: 30
Study: 34360267

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention consisting of education and feedback on reducing benzodiazepine prescriptions
Number of subjects: 40
Study: 32442746

Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT) during the immobilisation period, in addition to conventional physiotherapy.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional physiotherapy program applied for 4 weeks after 2 weeks of immobilisation.
Number of subjects: 35
Study: 35879623

Group type: EXPERIMENTAL
Intervention: Passive Ultrasonic Irrigation (PUI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: LAI/SSP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SWEEPS/flat-tip
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SWEEPS/radial-tip
Number of subjects: 40
Study: 35557301

Group type: EXPERIMENTAL
Intervention: VR module
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interactive 2D module
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3D-printed models
Number of subjects: 0
Study: 33278898

Group type: EXPERIMENTAL
Intervention: Oral Glucose Tolerance Test (OGTT)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Glycated Hemoglobin (HbA1c)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Comparison of OGTT and HbA1c
Number of subjects: 130
Study: 36416166

Group type: EXPERIMENTAL
Intervention: Pedometer-based walking program plus TheraBand resistance exercise (7,500 steps/day for 5 days/week, resistance exercise twice a week)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Pedometer-based walking program plus TheraBand resistance exercise
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (routine daily activities)
Number of subjects: 57
Study: 33576075

Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 6629

Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 6629
Study: 32719246

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Swallowing-sparing IMRT
Number of subjects: 0
Study: 35661040

Group type: EXPERIMENTAL
Intervention: Manual measurement of nineteen body dimensions
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Test-retest reliability assessment using Intraclass Correlation Coefficient (ICC2:1)
Number of subjects: 317
Study: 35060798

Group type: EXPERIMENTAL
Intervention: Tobacco 21 implementation
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Cohort 1 (pre-post Tobacco 21)
Number of subjects: 1140

Group type: EXPERIMENTAL
Intervention: Tobacco 21
Number of subjects: 1140
Study: 33879806

Group type: COMPARATOR
Intervention: Urinary miRNA biomarkers (miR‐1273f, miR‐619‐5p, miR‐150‐3p, miR‐4327, and miR‐3135b)
Number of subjects: 193
Study: 35731136

Group type: EXPERIMENTAL
Intervention: Cholesterol efflux capacity (CEC) of serum high-density lipoprotein (HDL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum HDL cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum ApoA1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol efflux capacity (CEC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: A decline in CEC
Number of subjects: 0
Study: 33347597

Group type: EXPERIMENTAL
Intervention: IUI‐FSH
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: IUI‐CC
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: IVF‐MNC
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: IVF‐SET
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: IUI‐OS
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 472
Study: 33858838

Group type: EXPERIMENTAL
Intervention: Circumpapillary retinal nerve fibre layer thickness (RNFLT) measurement using spectral‐domain optical coherence tomography (OCT)
Number of subjects: 667
Study: 35696165

Group type: COMPARATOR
Intervention: Outbound telephone call only
Number of subjects: 16045

Group type: COMPARATOR
Intervention: Text plus outbound call
Number of subjects: 16045

Group type: COMPARATOR
Intervention: Text plus inbound call
Number of subjects: 16045

Group type: EXPERIMENTAL
Intervention: Standard messaging
Number of subjects: 16045

Group type: EXPERIMENTAL
Intervention: Clinician endorsement
Number of subjects: 16045

Group type: EXPERIMENTAL
Intervention: Scarcity
Number of subjects: 16045

Group type: EXPERIMENTAL
Intervention: Endowment
Number of subjects: 16045
Study: 34924999

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.15 mg/kg combined with propofol
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.2 mg/kg combined with propofol
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Nalbuphine combined with propofol
Number of subjects: 75
Study: 33485959

Group type: EXPERIMENTAL
Intervention: BDP/FF/G (beclomethasone dipropionate, formoterol fumarate, glycopyrronium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: BDP/FF (beclomethasone dipropionate, formoterol fumarate)
Number of subjects: 0
Study: 33196634

Group type: EXPERIMENTAL
Intervention: Mobile app intervention group (n=60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n=60)
Number of subjects: 120
Study: 35773027

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (FC) 4 g
Number of subjects: 735

Group type: COMPARATOR
Intervention: Cryoprecipitate (10 U)
Number of subjects: 735
Study: 34911904

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study: 33710111

Group type: EXPERIMENTAL
Intervention: Prolonged prophylactic systemic antibiotics (PPSA) administered for the duration of the drain
Number of subjects: 336

Group type: COMPARATOR
Intervention: Non-prolonged prophylactic systemic antibiotics (non-PPSA) administered for 24 hours postoperatively
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: PPSA
Number of subjects: 336

Group type: COMPARATOR
Intervention: Non-PPSA
Number of subjects: 336
Study: 32014855

Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS)
Number of subjects: 3
Study: 34622731

Group type: EXPERIMENTAL
Intervention: Oral D-methionine (D-met)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 34960093

Group type: EXPERIMENTAL
Intervention: INV-MFGM (investigational cow's milk-based IF/100 kcal: 1.9 g protein, 1.2 mg iron, 25 mg ARA and whey protein-lipid concentrate, 5 g/L (source of bMFGM))
Number of subjects: 373

Group type: COMPARATOR
Intervention: Control (marketed, routine cow's milk-based IF/100 kcal: 2.1 g protein, 1.8 mg iron, 34 mg ARA)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: INV-MFGM
Number of subjects: 373

Group type: COMPARATOR
Intervention: Control
Number of subjects: 373
Study: 35807790

Group type: EXPERIMENTAL
Intervention: PA + MMNS
Number of subjects: 932

Group type: COMPARATOR
Intervention: PA + placebo
Number of subjects: 932

Group type: COMPARATOR
Intervention: MMNS
Number of subjects: 932

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 932

Group type: COMPARATOR
Intervention: Combined intervention group
Number of subjects: 932
Study: 34515308

Group type: EXPERIMENTAL
Intervention: Total meal-replacement diet (energy intake restricted by 65-75% for 16 weeks, followed by a food-based diet restricted by 25-35% until 52 weeks)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Food-based diet for the entire 52-week period
Number of subjects: 79
Study: 33843705

Group type: EXPERIMENTAL
Intervention: Posture control training using a virtual reality (VR) training program
Number of subjects: 20
Study: 34001705

Group type: EXPERIMENTAL
Intervention: Intervention app providing automated feedback on self-reported PrEP use
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control app allowing daily reporting of sexual behaviour and medication intake
Number of subjects: 229
Study: 35141780

Group type: EXPERIMENTAL
Intervention: Combined clinical and radiomics model
Number of subjects: 302

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 302

Group type: COMPARATOR
Intervention: Radiomics model
Number of subjects: 302

Group type: COMPARATOR
Intervention: Human performance
Number of subjects: 302
Study: 34182998

Group type: EXPERIMENTAL
Intervention: BGF 320/14.4/10 μg
Number of subjects: 948

Group type: COMPARATOR
Intervention: GFF 14.4/10 μg
Number of subjects: 948

Group type: COMPARATOR
Intervention: BFF 320/10 μg
Number of subjects: 948

Group type: COMPARATOR
Intervention: BUD/FORM DPI 400/12 μg
Number of subjects: 948
Study: 33511816

Group type: EXPERIMENTAL
Intervention: HIIE prescribed and self‐regulated by RPE (HIIE<inf>RPE</inf>)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HIIE prescribed and regulated by HR response to cardiopulmonary exercise test (HIIE<inf>HR</inf>)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control session (25 minutes of seated resting)
Number of subjects: 12
Study: 33852958

Group type: EXPERIMENTAL
Intervention: Time-varying CPR (TVCPR), alternating between 100 and 200 compressions per minute (cpm) every 6 seconds
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (guidelines CPR)
Number of subjects: 20
Study: 32179502

Group type: EXPERIMENTAL
Intervention: Emotional Intelligence Training based on Bar-On Combined Model, provided in eight 90-minute sessions for eight weeks.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 70
Study: 35906688

Group type: EXPERIMENTAL
Intervention: Electronic cigarette
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Heated tobacco product
Number of subjects: 11
Study: 33334571

Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg twice daily
Number of subjects: 303

Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 303
Study: 34332374

Group type: EXPERIMENTAL
Intervention: Training in Affect Recognition (TAR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Social Cognition and Interaction Training (SCIT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both TAR and SCIT
Number of subjects: 100
Study: 33083487

Group type: EXPERIMENTAL
Intervention: Deep cervical flexor (DCF) training and postural education
Number of subjects: 30

Group type: COMPARATOR
Intervention: Postural education only
Number of subjects: 30
Study: 32552074

Group type: EXPERIMENTAL
Intervention: FindMyApps training and selection tool
Number of subjects: 20

Group type: COMPARATOR
Intervention: Short tablet training (Control)
Number of subjects: 20
Study: 34118123

Group type: EXPERIMENTAL
Intervention: 50 mg of dexketoprofen
Number of subjects: 200

Group type: COMPARATOR
Intervention: 1000 mg of paracetamol
Number of subjects: 200
Study: 35933133

Group type: EXPERIMENTAL
Intervention: Moderate TR
Number of subjects: 13068

Group type: EXPERIMENTAL
Intervention: Moderate-severe TR
Number of subjects: 13068

Group type: EXPERIMENTAL
Intervention: Severe TR
Number of subjects: 13068

Group type: EXPERIMENTAL
Intervention: TRIO score
Number of subjects: 13068